Viewing Study NCT02124850

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:55 PM

Ignite Modification Date: 2026-01-13 @ 1:20 PM

Study NCT ID: NCT02124850

Status: TERMINATED

Last Update Posted: 2019-10-25

First Post: 2014-04-22

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab

Sponsor: Celgene

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module